News from breckenridge pharmaceutical, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 23, 2014, 13:00 ET

Breckenridge Pharmaceutical, Inc. Announces Paragraph IV ANDA Litigation with Cephalon, Inc. for its ANDA Bendamustine HCl Powder for IV (Treanda®)

 Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for bendamustine hydrochloride...

Sep 11, 2013, 17:13 ET

Breckenridge Completes Acquisition of Certain Cypress Products from Pernix Therapeutics

 Breckenridge Pharmaceutical, Inc. announced today that it has completed its acquisition of certain Cypress Pharmaceutical, Inc. product assets...

Aug 09, 2013, 08:17 ET

Breckenridge Enters Into Agreement to Acquire Certain Cypress Assets from Pernix Therapeutics

 Breckenridge Pharmaceutical, Inc. announced today that it has entered into an agreement to acquire from Pernix Therapeutics, certain assets...

Jul 09, 2013, 14:52 ET

Breckenridge Announces Dismissal of Various Lawsuits Against Macoven Pharmaceuticals in Return for Macoven's Discontinuance of Certain Products

 Breckenridge Pharmaceutical, Inc. announced today that Nestle Health Science-Pamlab and Merck & Cie have dismissed their patent litigation...

Jul 03, 2013, 10:31 ET

Breckenridge Announces Approval of Rizatriptan Benzoate ODT (Orally Disintegrating Tablets)

 Breckenridge Pharmaceutical, Inc. announces the immediate launch of Rizatriptan Benzoate Orally Disintegrating Tablets.  The U.S. Food...

Jun 28, 2013, 11:47 ET

Breckenridge Announces Paragraph IV ANDA Litigation with Par Pharmaceutical & Alkermes Pharma Ireland Limited for its ANDA Megestrol Acetate Oral Suspension (Megace® ES)

Breckenridge Pharmaceutical, Inc. announced today that it has filed an ANDA with a Paragraph IV certification for Megestrol Acetate Oral...

Mar 26, 2013, 12:33 ET

Breckenridge announces agreement with Aptalis Pharmatech to market Propranolol Hydrochloride Extended-Release Capsules

 Breckenridge Pharmaceutical, Inc. announced today that it has entered into an agreement with Aptalis Pharmatech, Inc. to market Propranolol...

Feb 13, 2013, 15:10 ET

Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets

 Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Pioglitazone Hydrochloride Tablets. The U.S. Food and Drug...

Dec 30, 2012, 10:00 ET

Breckenridge Announces Approval of Rizatriptan Benzoate Tablets

 Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Rizatriptan Benzoate Tablets.  The U.S. Food and Drug...

Dec 18, 2012, 16:51 ET

Breckenridge Announces Approval for Lansoprazole Delayed-Release Rx Capsules

 Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Prescription Lansoprazole Delayed-Release Capsules.  The U.S....

Oct 12, 2012, 15:02 ET

Breckenridge announces agreement with Marksans Pharma, Ltd. to market Gabapentin Capsules

 Breckenridge Pharmaceutical, Inc. announced today that it has entered into an agreement with Marksans Pharma, Ltd to market its Abbreviated...

Oct 03, 2012, 15:13 ET

Breckenridge announces agreement with Ajanta Pharma, Ltd. to market Risperidone Tablets

 Breckenridge Pharmaceutical, Inc. announced today that it has entered into an agreement with Ajanta Pharma, Ltd. to market its Abbreviated New...

Jun 27, 2012, 20:17 ET

Breckenridge and Alembic Announce Paragraph IV ANDA Litigation with Pfizer on Desvenlafaxine tablets (Pristiq®)

 Breckenridge Pharmaceutical, Inc. announced today that Breckenridge and Alembic Pharmaceuticals Limited were named codefendants in a Paragraph...

Jun 14, 2012, 14:47 ET

Breckenridge and Alembic Announce Settlement with Novartis of PIV litigation on Rivastigmine Tartrate Capsules

BOCA RATON, Fla., June 14, 2012 /PRNewswire/ --  Breckenridge Pharmaceutical, Inc. announced today that Breckenridge and Alembic...

May 04, 2012, 14:58 ET

Breckenridge signs Generic Agreement with Zhejiang Huahai Pharmaceuticals Co., Ltd.

 Breckenridge Pharmaceutical, Inc. announced today that it has finalized its agreement with Zhejiang Huahai Pharmaceuticals Co., Ltd....

Jan 06, 2012, 15:09 ET

Breckenridge Announces Seven Paragraph IV ANDAs in 2011

Breckenridge Pharmaceutical, Inc.announced that it has submitted Paragraph IV (PIV) certifications for seven (7) different Abbreviated New Drug...

Dec 09, 2011, 15:22 ET

Breckenridge Announces Approval of Methscopolamine Bromide Tablets

 Breckenridge Pharmaceutical, Inc. announced that the U.S. Food and Drug Administration granted final approval for their Abbreviated New Drug...

Jun 10, 2011, 12:22 ET

Breckenridge Announces Approval of Generic Activella® 0.5mg/0.1mg Tablets

Breckenridge Pharmaceutical, Inc. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's...

Jun 10, 2011, 11:51 ET

Breckenridge Announces Approval of Letrozole Tablets

Breckenridge Pharmaceutical, Inc. announced today the immediate launch of Letrozole 2.5 mg Tablets. The U.S. Food and Drug Administration granted...

May 16, 2011, 11:43 ET

Breckenridge Pharmaceutical Announces Settlement of Actos® (Pioglitazone Hydrochloride) Patent Litigation

Breckenridge Pharmaceutical, Inc. announced that Breckenridge and Synthon Pharmaceuticals, Inc. have reached an agreement with Takeda...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge